Kokku publikatsioone: 200
| Artiklid rahvusvahelistes ajakirjades | |
| 1 | Adoberg A., Paats J., Arund J., Dhondt A., Fridolin I., Glorieux G., Holmar J., Lauri K., Leis L., Luman M., Pilt K., Uhlin F., Tanner R. Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate PUBMED Toxins: 14 (9), Artikkel nr 610, 2022 |
| 2 | Ala-Kokko T., Erikson K., Koskenkari J., Laurila J., Kortelainen J. Monitoring of nighttime EEG slow-wave activity during dexmedetomidine infusion in patients with hyperactive ICU delirium: An observational pilot study PUBMED Acta Anaesthesiologica Scandinavica: 66 (10), 1211-1218, 2022 |
| 3 | Banach M., Reiner Z., Cicero AFG., Sabouret P., Viigimaa M., Sahebkar A., Postadzhiyan A., Gaita D., Pella D., Penson PE. 2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy PUBMED Archives of Medical Science: 18 (6), 1429-1434, 2022 |
| 4 | Berger MM., Shenkin A., Schweinlin A., Amrein K., Augsburger M., Biesalski HK., Bischoff SC., Casaer MP., Gundogan K., Lepp HL., de Man AME., Muscogiuri G., Pietka M., Pironi L., Rezzi S., Cuerda C. ESPEN micronutrient guideline PUBMED Clinical Nutrition: 41 (6), 1357-1424, 2022 |
| 5 | Blöndal M., Ainla T., Eha J., Lõiveke P., Marandi T., Saar A., Veldre G., Edfors R., Lewinter C., Jernberg T., Jortveit J., Halvorsen S., Becker D., Csanadi Z., Ferenci T., Andreka P., Janosi A. Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries PUBMED European Heart Journal. Quality of Care & Clinical Outcomes: 8 (3), 307-314, 2022 |
| 6 | Boria F., Chiva L.,Chacon E., Zanagnolo V., Fagotti A., Kucukmetin A., Mom C., Chakalova G., Shamistan A., Malzoni M., ..., Kukk K., SUCCOR study group Autorite grupp:Leht M., Uppin A. SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer International Journal of Gynecological Cancer: 32 (10), 1236-1243, 2022 |
| 7 | Boriani G., Vitolo M., Malavasi VL., Proietti M., Fantecchi E., Diemberger I., Fauchier L., Marin F., Nabauer M., Potpara TS., ..., ESC-EHRA EORP-AF Long-Term General Registry Investigators Autorite grupp:Muda P., Vettus R. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry PUBMED European Journal of Preventive Cardiology: 29 (15), 1967-1981, 2022 |
| 8 | Chacon E., Manzour N., Zanagnolo V., Querleu D., Nunez-Cordoba JM., Martin-Calvo N., Capilna ME., Fagotti A., Kucukmetin A., Mom C., ..., Kukk K., SUCCOR study group Autorite grupp:Leht M., Uppin A. SUCCOR cone study: conization before radical hysterectomy PUBMED International Journal of Gynecological Cancer: 32 (2), 117-124, 2022 |
| 9 | Cimci M., Polad J., Mamas M., Iniguez-Romo A., Chevalier B., Abhaichand R., Aminian A., Roguin A., Maluenda G., Angioi M., Cassel G., Kuramitsu S., Jacobs L., Debrus R., Malik F., Hildick-Smith D., Laanmets P., Roffi M., e-ULTIMASTER investigators Outcomes and regional differences in practice in a worldwide coronary stent registry PUBMED Heart: 108 (16), 1310-1318, 2022 |
| 10 | Clark D., Joannides A., Adeleye AO., Bajamal AH., Bashford T., Biluts H., Budohoski K., Ercole A., Fernandez-Mendez R., Figaji A., ..., Global Neurotrauma Outcomes Study collaborative Autorite grupp:Asser A., Kõiv K., Kõiv L., Rätsep T. Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort study PUBMED The Lancet Neurology: 21 (5), 438-449, 2022 |
| 11 | Cook A., Sharland M., Yau Y., PediBSI Group, Bielicki J. Autorite grupp:Kõljalg S., Jürna-Ellam M. Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA) PUBMED Expert Review of Anti-infective Therapy: 20 (3), 445-456, 2022 |
| 12 | Crulli B., Dines AM., Blanco G., Giraudon I., Eyer F., Liechti ME., Miro O., Hovda KE., Heyerdahl F., Yates C., Vallersnes OM., Wood DM., Dargan PI., Euro-DEN Plus Research Group Autorite grupp:Põld K. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019 PUBMED Clinical Toxicology: 60 (12), 1318-1327, 2022 |
| 13 | Ding WY., Potpara TS., Blomström-Lundqvist C., Boriani G., Marin F., Fauchier L., Lip GYH., ESC-EHRA EORP-AF Long-Term General Registry Investigators Autorite grupp:Muda P., Vettus R. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry PUBMED European Journal of Clinical Investigation: 52 (6), Artikkel nr e13745, 2022 |
| 14 | Ding WY., Proietti M., Boriani G., Fauchier L., Blomström-Lundqvist C., Marin F., Potpara TS., Lip GYH., ESC-EHRA EORP-AF Long-Term General Registry Investigators Autorite grupp:Muda P., Vettus R. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry PUBMED Europace: 24 (5), 721-728, 2022 |
| 15 | Driemeyer C., Falci DR., Hoenigl M., Cornely OA., Chakrabarti A., Gangneux JP., Segal E., Jürna-Ellam M., Matos T., Meis JF., Perfect JR., Arsenijevic VA., Mares M., Serban DE., Pasqualotto AC. The current state of Clinical Mycology in Eastern and South-Eastern Europe PUBMED Medical Mycology: 60 (4), Artikkel nr myac017, 2022 |
| 16 | Edfors R., Jernberg T., Lewinter C., Blöndal M., Eha J., Lõiveke P., Marandi T., Ainla T., Saar A., Veldre G., Ferenci T., Andreka P., Janosi A., Jortveit J., Halvorsen S. Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction - novel insights from four national European continuous real-world registries PUBMED European Heart Journal. Quality of Care & Clinical Outcomes: 8 (4), 429-436, 2022 |
| 17 | Eger K., Paroczai D., Bacon A., Schleich F., Sergejeva S., Bourdin A., Vachier I., Zervas E., Katsoulis K., Papapetrou D., ... The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good? PUBMED ERJ Open Research: 8 (2), Artikkel nr 00065-2022, 2022 |
| 18 | Einstein AJ., Hirschfeld C., Williams MC., Vitola JV., Better N., Villines TC., Cerci R., Shaw LJ., Choi AD., Dorbala S., ..., INCAPS COVID 2 Investigators Group Autorite grupp:Liiver A. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19 PUBMED Journal of the American College of Cardiology: 79 (20), 2001-2017, 2022 |
| 19 | Eroglu Z., Broman KK., Thompson JF., Nijhuis A., Hieken TJ., Kottschade L., Farma JM., Hotz M., Deneve J., Fleming M., ..., Teras J. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection PUBMED Journal for ImmunoTherapy of Cancer: 10 (8), Artikkel nr e004417, 2022 |
| 20 | Frix AN., Heaney LG., Dahlen B., Mihaltan F., Sergejeva S., Popovic-Grle S., Sedlak V., Lehtimäki L., Bourdin A., Korn S., ... Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study PUBMED ERJ Open Research: 8 (4), Artikkel nr 00273-2022, 2022 |
| 21 | Fuchs CS., Özgüroglu M., Bang YJ., Di Bartolomeo M., Mandala M., Ryu MH., Fornaro L., Olesinski T., Caglevic C., Chung HC., ..., Elme A. Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial PUBMED Gastric Cancer: 25 (1), 197-206, 2022 |
| 22 | Glikson M., Nielsen JC., Kronborg MB., Michowitz Y., Auricchio A., Barbash IM., Barrabes JA., Boriani G., Braunschweig F., Brignole M., ... Autorite grupp:Voitk J. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy PUBMED Europace: 24 (1), 71-164, 2022 |
| 23 | GlobalSurg Collaborative and NIHR Global Health Research Unit on Global Surgery Autorite grupp:Kütner S., Melnik P., Seire I., Teras J., Ümarik T., Teppo S. Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study PUBMED The Lancet Global Health: 10 (7), e1003-e1011, 2022 |
| 24 | Goncalves BP., Hall M., Jassat W., Balan V., Murthy S., Kartsonaki C., Semple MG., Rojek A., Baruch J., Reyes LF., ..., ISARIC Clinical Characterisation Group Autorite grupp:Rätsep I. An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients PUBMED eLife: 11, Artikkel nr e80556, 2022 |
| 25 | Grüßer L., Keszei A., Coburn M., Rossaint R., Ziemann S., Kowark A., ETPOS Study Group Autorite grupp:Karjagin J., Rokk A., Sõrmus A., Rätsep I., Oganjan J., Smirnova N., Kivik P. Intraoperative transfusion practices and perioperative outcome in the European elderly: A secondary analysis of the observational ETPOS study PUBMED PLoS ONE: 17 (1), Artikkel nr e0262110, 2022 |
| 26 | Hagström E., Steg PG., Szarek M., Bhatt DL., Bittner VA., Danchin N., Diaz R., Goodman SG., Harrington RA., Jukema JW., ..., ODYSSEY OUTCOMES Investigators Autorite grupp:Viigimaa M. Apolipoprotein B., Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab PUBMED Circulation: 146 (9), 657-672, 2022 |
| 27 | Heier EC., Eyer F., Rabe C., Geith S., Dargan PI., Wood DM., Heyerdahl F., Dines AM., Giraudon I., Hovda KE., Yates C., Vallersnes OM., Miro O., Liechti ME., Zellner T., Euro-DEN Research Group Autorite grupp:Põld K. Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs PUBMED European Journal of Emergency Medicine: 29 (4), 291-300, 2022 |
| 28 | Hellgren T., Blöndal M., Jortveit J., Ferenci T., Faxen J., Lewinter C., Eha J., Lõiveke P., Marandi T., Ainla T., Saar A., Veldre G., Andreka P., Halvorsen S., Janosi A., Edfors R. Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries PUBMED European Heart Journal Open: 2 (4), Artikkel nr oeac042, 2022 |
| 29 | Hendricks LAJ., Hoogerbrugge N., Venselaar H., Aretz S., Spier I., Legius E., Brems H., de Putter R., Claes KBM., Evans DG., ..., Roht L. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort PUBMED European Journal of Medical Genetics: 65 (12), Artikkel nr 104632, 2022 |
| 30 | Holmberg CJ., Ny L., Hieken TJ., Block MS., Carr MJ., Sondak VK., Örtenwall C., Katsarelias D., Dimitriou F., Menzies AM., ..., Teras J. The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study PUBMED European Journal of Cancer: 169, 210-222, 2022 |
| 31 | Humbert M., Kovacs G., Hoeper MM., Badagliacca R., Berger RMF., Brida M., Carlsen J., Coats AJS., Escribano-Subias P., Ferrari P., ... Autorite grupp:Anton L. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension PUBMED European Heart Journal: 43 (38), 3618-3731, 2022 |
| 32 | Innos K., Paapsi K., Alas I., Baum P., Kivi M., Kovtun M., Okas R., Pokker H., Rajevskaja O., Rautio A., Saretok M., Valk E., Žarkovski M., Denissov G., Lang K. Evidence of overestimating prostate cancer mortality in Estonia: a population-based study PUBMED Scandinavian Journal of Urology: 56 (5-6), 359-364, 2022 |
| 33 | ISARIC Clinical Characterization Group, Garcia-Gallo E., Merson L., Kennon K., Kelly S., Citarella BW., Fryer DV., Shrapnel S., Lee J., Duque S., ... Autorite grupp:Beljantsev A., Maasikas O., Mihnovitš V., Rätsep I. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 PUBMED Scientific Data: 9 (1), Artikkel nr 454, 2022 |
| 34 | Jaago M., Rähni A., Pupina N., Pihlak A., Sadam H., Tuvikene J., Avarlaid A., Planken A., Planken M., Haring L., Vasar E., Bacevic M., Lambert F., Kalso E., Pussinen P., Tienari PJ., Vaheri A., Lindholm D., Timmusk T., Ghaemmaghami AM., Palm K. Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naive individuals PUBMED Scientific Reports: 12 (1), Artikkel nr 16817, 2022 |
| 35 | Jaakonmäki N., Zedde M., Sarkanen T., Martinez-Majander N., Tuohinen S., Sinisalo J., Ryödi E., Autere J., Hedman M., Junttola U., ..., Kõrv L., Kõrv J. Obesity and the Risk of Cryptogenic Ischemic Stroke in Young Adults PUBMED Journal of Stroke and Cerebrovascular Diseases: 31 (5), Artikkel nr 106380, 2022 |
| 36 | Jalasto J., Lassmann-Klee P., Schyllert C., Luukkonen R., Meren M., Larsson M., Põlluste J., Sundblad BM., Lindqvist A., Krokstad S., Kankaanranta H., Kauppi P., Sovijärvi A., Haahtela T., Backman H., Lundbäck B., Piirilä P. Occupation, socioeconomic status and chronic obstructive respiratory diseases - The EpiLung study in Finland, Estonia and Sweden PUBMED Respiratory Medicine: 191, Artikkel nr 106403, 2022 |
| 37 | Janssen BDE., van den Boogaard MH., Lichtenbelt K., Seaby EG., Stals K., Ellard S., Newbury-Ecob R., Dixit A., Roht L., Pajusalu S., Õunap K., ... De novo putative loss-of-function variants in TAF4 are associated with a neuro-developmental disorder PUBMED Human Mutation: 43 (12), 1844-1851, 2022 |
| 38 | Jürgens H., Roht L., Leitsalu L., Nõukas M., Palover M., Nikopensius T., Reigo A., Kals M., Kallak K., Kütner R., Budrikas K., Kuusk S., Valvere V., Laidre P., Toome K., Rekker K., Tooming M., Murumets Ü., Kahre T., Kruuv-Käo K., Õunap K., Padrik P., Metspalu A., Esko T., Fischer K., Tõnisson N. Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting PUBMED Frontiers in Genetics: 13, Artikkel nr 881100, 2022 |
| 39 | Kangro K., Kurašin M., Gildemann K., Sankovski E., Žusinaite E., Lello LS., Pert R., Kavak A., Poikalainen V., Lepasalu L., Kuusk M., Pau R., Piiskop S., Rom S., Oltjer R., Tiirik K., Kogermann K., Plaas M., Tiirats T., Aasmäe B., Plaas M., Mumm K., Krinka D., Talpsep E., Kadaja M., Gerhold JM., Planken A., Tover A., Merits A., Männik A., Ustav M. Jr., Ustav M. Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents PUBMED PLoS ONE: 17 (6), Artikkel nr e0268806, 2022 |
| 40 | Kobo O., Saada M., Laanmets P., Karageorgiev D., Routledge H., Crowley J., Baello P., Requena JB., Spano F., Perez L., Jimenez Mazuecos JM., Mamas MA., Roguin A. Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry PUBMED Atherosclerosis: 344, 71-77, 2022 |
| 41 | Krieger B., Hallik R., Kala K., Ülper K., Polonski M. Validation of mobile-based funduscope for diabetic retinopathy screening in Estonia PUBMED European Journal of Ophthalmology: 32 (1), 508-513, 2022 |
| 42 | Kroese TE., van Hillegersberg R., Schoppmann S., Deseyne PRAJ., Nafteux P., Obermannova R., Nordsmark M., Pfeiffer P., Hawkins MA., Smyth E., ..., Elme A. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe PUBMED European Journal of Cancer: 164, 18-29, 2022 |
| 43 | Kulasekararaj AG., Griffin M., Langemeijer S., Usuki K., Kulagin A., Ogawa M., Yu J., Mujeebuddin A., Nishimura JI., Lee JW., Peffault de Latour R., 301/302 Study Group Autorite grupp:Viigimaa I. Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies PUBMED European Journal of Haematology: 109 (3), 205-214, 2022 |
| 44 | Kurg K., Planken A., Kurg R. Proteomic and Biochemical Analysis of Extracellular Vesicles Isolated from Blood Serum of Patients with Melanoma Separations: 9 (4), Artikkel nr 86, 2022 |
| 45 | Li Bassi G., Gibbons K., Suen JY., Dalton HJ., White N., Corley A., Shrapnel S., Hinton S., Forsyth S., Laffey JG., ..., COVID-19 Critical Care Consortium Autorite grupp:Rätsep I., Õigus G., Erikson K., Enneveer L., Maasikas O., Beljantsev A., Mihnovitš V. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis PUBMED Critical Care: 26 (1), Artikkel nr 141, 2022 |
| 46 | Lip GYH., Kotalczyk A., Teutsch C., Diener HC., Dubner SJ., Halperin JL., Ma CS., Rothman KJ., Marler S., Gurusamy VK., Huisman MV., GLORIA-AF Investigators Autorite grupp:Kampus P. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry PUBMED Clinical Research in Cardiology: 111 (5), 560-573, 2022 |
| 47 | Loberti L., Bruno LP., Granata S., Doddato G., Resciniti S., Fava F., Carullo M., Rahikkala E., Jouret G., Menke LA., ..., Reimand T., Lokke H., Õunap K., Zordania R., Muru K., Roht L., Teek R., Thomson U. Natural history of KBG syndrome in a large European cohort PUBMED Human Molecular Genetics: 31 (24), 4131-4142, 2022 |
| 48 | Lõokene M., Markov N., Nikander M., Neuvonen T., Dilkov D. Reduction of symptoms in patients with major depressive disorder after transcranial direct current stimulation treatment: A real-world study Journal of Affective Disorders Reports: 8, Artikkel nr 100347, 2022 |
| 49 | Lyon AR., Lopez-Fernandez T., Couch LS., Asteggiano R., Aznar MC., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., ..., ESC Scientific Document Group Autorite grupp:Vettus R. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) PUBMED European Heart Journal: 43 (41), 4229-4361, 2022 |
| 50 | Malavasi VL., Vitolo M., Proietti M., Diemberger I., Fauchier L., Marin F., Nabauer M., Potpara TS., Dan GA., Kalarus Z., ..., ESC-EHRA EORP-AF Long-Term General Registry Investigators Autorite grupp:Muda P., Vettus R. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry PUBMED European Journal of Clinical Investigation: 52 (7), Artikkel nr e13773, 2022 |
| 51 | Manzour N., Chiva L., Chacon E., Martin-Calvo N., Boria F., Minguez JA., Alcazar JL., SUCCOR Study Group Autorite grupp:Kukk K., Leht M., Uppin A. SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer PUBMED Annals of Surgical Oncology: 29 (8), 4819-4829, 2022 |
| 52 | Martin-Loeches I., Timsit JF., Kollef MH., Wunderink RG., Shime N., Novacek M., Kivistik Ü., Rea-Neto A., Bruno CJ., Huntington JA., Lin G., Jensen EH., Motyl M., Yu B., Gates D., Butterton JR., Rhee EG. Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia PUBMED Journal of Antimicrobial Chemotherapy: 77 (4), 1166-1177, 2022 |
| 53 | Medved S., Žaja N., Gazdag G., Lengvenyte A., Mörkl S., Mucci F., Ristic I., Jerotic S., Regente JF., Ivanovic I., ..., Lõokene M. Preliminary Assessment of Pre-Electroconvulsive Therapy Evaluation Practices in European Countries: The Need for Guidelines PUBMED Journal of ECT: 38 (4), 230-237, 2022 |
| 54 | Murruste M., Kirsimägi Ü., Kase K., Veršinina T., Talving P., Lepner U. Complications of chronic pancreatitis prior to and following surgical treatment: A proposal for classification PUBMED World Journal of Clinical Cases: 10 (22), 7808-7824, 2022 |
| 55 | Naaber P., Tserel L., Kangro K., Punapart M., Sepp E., Jürjenson V., Kärner J., Haljasmägi L., Haljasorg U., Kuusk M., Sankovski E., Planken A., Ustav M., Žusinaite E., Gerhold JM., Kisand K., Peterson P. Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine PUBMED Cell Reports Medicine: 3 (8), Artikkel nr 100716, 2022 |
| 56 | Nurm M., Reigo A., Nõukas M., Leitsalu L., Nikopensius T., Palover M., Annilo T., Alver M., Saar A., Marandi T., Ainla T., Metspalu A., Esko T., Tõnisson N. Do Biobank Recall Studies Matter? Long-Term Follow-Up of Research Participants With Familial Hypercholesterolemia PUBMED Frontiers in Genetics: 13, Artikkel nr 936131, 2022 |
| 57 | O'Brien M., Paz-Ares L., Marreaud S., Dafni U., Oselin K., Havel L., Esteban E., Isla D., Martinez-Marti A., Faehling M., ... Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial PUBMED The Lancet Oncology: 23 (10), 1274-1286, 2022 |
| 58 | Paz-Ares L., O'Brien MER., Mauer M., Dafni U., Oselin K., Havel L., Gonzalez EE., Isla D., Martinez-Marti A., Faehling M., ... VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 e PEARLS/KEYNOTE-091 study Annals of Oncology: 33 (4), 451-453, 2022 |
| 59 | Pauklin P., Zilmer M., Eha J., Tootsi K., Kals M., Kampus P. Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation PUBMED Oxidative Medicine and Cellular Longevity: Artikkel nr 4556671, 2022 |
| 60 | Peebo K., Saluveer E., Küünarpuu H., Orgse T., Harro J. First-episode psychosis integrative treatment: Estonian experience PUBMED Nordic Journal of Psychiatry: 76 (3), 207-214, 2022 |
| 61 | PelvEx Collaborative Autorite grupp:Teras J. Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative PUBMED Cancers: 14 (5), Artikkel nr 1161, 2022 |
| 62 | PelvEx Collaborative Autorite grupp:Teras J. Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline PUBMED British Journal of Surgery: 109 (12), 1251-1263, 2022 |
| 63 | Penson PE., Bruckert E., Marais D., Reiner Ž., Pirro M., Sahebkar A., Bajraktari G., Mirrakhimov E., Rizzo M., Mikhailidis DP., ..., International Lipid Expert Panel (ILEP) Autorite grupp:Viigimaa M. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) PUBMED Journal of Cachexia, Sarcopenia and Muscle: 13 (3), 1596-1622, 2022 |
| 64 | Pikta M., Vasse M., Smock KJ., Moser KA., Van Dievoet MA., Lejniece S., Szanto T., Bautista H., Nouadje G., Banys V. Establishing reference intervals for von Willebrand factor multimers PUBMED Journal of Medical Biochemistry: 41 (1), 115-121, 2022 |
| 65 | Proietti M., Romiti GF., Vitolo M., Harrison SL., Lane DA., Fauchier L., Marin F., Näbauer M., Potpara TS., Dan GA., Maggioni AP., Cesari M., Boriani G., Lip GYH., ESC-EHRA EORP-AF General Long-Term Registry Investigators Autorite grupp:Vettus R., Muda P. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe PUBMED Age and Ageing: 51 (8), Artikkel nr afac192, 2022 |
| 66 | Pupina N., Avarlaid A., Sadam H., Pihlak A., Jaago M., Tuvikene J., Rähni A., Planken A., Planken M., Kalso E., Tienari PJ., Nieminen JK., Seppänen MRJ., Vaheri A., Lindholm D., Sinisalo J., Pussinen P., Timmusk T., Palm K. Immune response to a conserved enteroviral epitope of the major capsid VP1 protein is associated with lower risk of cardiovascular disease PUBMED EBioMedicine: 76, Artikkel nr 103835, 2022 |
| 67 | Ratanachina J., Amaral AFS., De Matteis S., Lawin H., Mortimer K., Obaseki DO., Harrabi I., Denguezli M., Wouters EFM., Janson C., ..., Jõgi R., BOLD Collaborative Research Group Autorite grupp:Laja H., Ulst K., Zobel V. Association of respiratory symptoms and lung function with occupation in the multinational Burden of Obstructive Lung Disease (BOLD) study PUBMED European Respiratory Journal: 60 (4), Artikkel nr 2200469, 2022 |
| 68 | Raukas M., Metsna V., Tammaru M. Cross-cultural adaptation and validation of the Estonian version of the Oxford Knee Score PUBMED Acta Orthopaedica et Traumatologica Turcica: 56 (1), 53-57, 2022 |
| 69 | Reuter A., Rogge L., Monahan M., Kachapila M., Morton DG., Davies J., Vollmer S., NIHR Global Surgery Collaboration Autorite grupp:Talving P., Saar S., Reinsoo A. Global economic burden of unmet surgical need for appendicitis PUBMED British Journal of Surgery: 109 (10), 995-1003, 2022 |
| 70 | Reyes LF., Murthy S., Garcia-Gallo E., Merson L., Ibanez-Prada ED., Rello J., Fuentes YV., Martin-Loeches I., Bozza F., Duque S., ..., ISARIC Characterization Group Autorite grupp:Beljantsev A., Maasikas O., Mihnovitš V., Rätsep I. Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study PUBMED Critical Care: 26 (1), Artikkel nr 276, 2022 |
| 71 | Rips L., Luik M., Koovit T., Rahu M. Lower leg muscle recovery takes at least 12 months for functional tests to recover after late reconstruction of the tibialis posterior tendon retinaculum PUBMED BMJ Case Reports: 15 (1), Artikkel nr e247273, 2022 |
| 72 | Rips L., Toom A., Kuik R., Varblane A., Mölder H., Tammaru M., Kull M., Ööpik V., Kartus JT., Gapeyeva H., Rahu M. Seven-month wintertime supplementation of 1200 IU vitamin D has no effect on hand grip strength in young, physically active males: A randomized, controlled study PUBMED Journal of the International Society of Sports Nutrition: 19 (1), 437-454, 2022 |
| 73 | Roht L., Tooming M., Rekker K., Roomere H., Toome K., Murumets Ü., Šamarina U., Õunap K., Kahre T. The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021 PUBMED Frontiers in Genetics: 13, Artikkel nr 1020543, 2022 |
| 74 | Romiti GF., Proietti M., Vitolo M., Bonini N., Fawzy AM., Ding WY., Fauchier L., Marin F., Nabauer M., Dan GA., ..., ESC-EHRA EORP-AF General Long-Term Registry Investigators Autorite grupp:Muda P., Vettus R. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry PUBMED BMC Medicine: 20 (1), Artikkel nr 326, 2022 |
| 75 | Rubin DT., Dotan I., DuVall A., Bouhnik Y., Radford-Smith G., Higgins PDR., Mishkin DS., Arrisi P., Scalori A., Oh YS., Tole S., Chai A., Chamberlain-James K., Lacey S., McBride J., Panes J., HIBISCUS Study Group Autorite grupp:Kull K., Borissova J. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials PUBMED The Lancet Gastroenterology and Hepatology: 7 (1), 17-27, 2022 |
| 76 | Saar S., Jorgensen J., Lemma AN., Gaarder C., Naess PA., Leppäniemi A., Sallinen V., Pius R., Reinsoo A., Lepp J., Talving P. Selective non-operative management of penetrating abdominal injuries at Northern European trauma centers: the NordiPen Study PUBMED European Journal of Trauma and Emergency Surgery: 48 (3), 2023-2027, 2022 |
| 77 | Schjesvold FH., Dimopoulos MA., Delimpasi S., Robak P., Coriu D., Legiec W., Pour L., Špicka I., Masszi T., Doronin V., ..., OCEAN (OP-103) Investigators Autorite grupp:Palk K., Kaare A. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study PUBMED The Lancet Haematology: 9 (2), e98-e110, 2022 |
| 78 | Szanto T., Zetterberg E., Ramström S., Leinoe EB., Holme PA., Antovic JP., Holmström M., Onundarson PT., Pikta M., Vaide I., Olsson A., Magnusson M., Kärkkäinen S., Bitar M., Poulsen LH., Lassila R., Nordic Haemophilia Council Platelet function testing: Current practice among clinical centres in Northern Europe PUBMED Haemophilia: 28 (4), 642-648, 2022 |
| 79 | Tamm M., Kals M., Annilo T., Oselin K., Keerma K., Kivistik PA., Nurm M., Saare M., Jaal J., Tõnisson N. Prognostic Utility of Targeted Circulating Cell-Free DNA versus Formalin-Fixed Paraffin-Embedded DNA Mutation Analysis for Advanced Lung Cancer International Journal of Oncology Research: 5 (1), Artikkel nr 033, 2022 |
| 80 | Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D., Gale CP., Maggioni AP., Petersen SE., Huculeci R., Kazakiewicz D., ..., Atlas Writing Group, European Society of Cardiology Autorite grupp:Kampus P. European Society of Cardiology: cardiovascular disease statistics 2021 PUBMED European Heart Journal: 43 (8), 716-799, 2022 |
| 81 | Urner M., Barnett AG., Bassi GL., Brodie D., Dalton HJ., Ferguson ND., Heinsar S., Hodgson CL., Peek G., Shekar K., Suen JY., Fraser JF., Fan E., COVID-19 Critical Care Consortium Investigators Autorite grupp:Beljantsev A., Maasikas O., Mihnovitš V., Rätsep I., Õigus G., Enneveer L., Erikson K. Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study PUBMED BMJ: 377, Artikkel nr e068723, 2022 |
| 82 | Uusküla A., Keis A., Toompere K., Planken A., Rebrov K. Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: a study protocol PUBMED Trials: 23 (1), Artikkel nr 92, 2022 |
| 83 | van Veelen A., Elias J., van Dongen IM., Hoebers LPC., Claessen BEPM., Ramunddal T., Laanmets P., Eriksen E., van der Schaaf RJ., Nijveldt R., Henriques JPS., Hirsch A. Recovery of right ventricular function and strain in patients with ST-segment elevation myocardial infarction and concurrent chronic total occlusion PUBMED International Journal of Cardiovascular Imaging: 38 (3), 631-641, 2022 |
| 84 | Viigimaa M., Jürisson M., Pisarev H., Kalda R., Alavere H., Irs A., Saar A., Fischer K., Läll K., Kruuv-Käo K., Mars N., Widen E., Ripatti S., Metspalu A. Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study PUBMED European Heart Journal Open: 2 (6), Artikkel nr oeac079, 2022 |
| 85 | Örd L., Marandi T., Märk M., Raidjuk L., Kostjuk J., Banys V., Krause K., Pikta M. Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration PUBMED Clinical and Applied Thrombosis/Hemostasis: 28, Artikkel nr 10760296221084307, 2022 |
| Artiklid "Eesti Arstis" | |
| 1 | Adoberg A., Auerbach A., Telling K., Mihnovitš V., Pertsev I., Kivistik Ü., Seppet J., Riispere Ž., Kõlvald K. Orellaniinimürgistusest põhjustatud neerukahjustus – haigusjuhtude kirjeldus ja kirjanduse ülevaade Eesti Arst: 101 (1), 43-48, 2022 |
| 2 | Ainla T. Ideest teostuseni − müokardiinfarktiregistri teekond riikliku registrini 2000−2011 Eesti Arst: 101 (Lisa 1), 3-6, 2022 |
| 3 | Jakobson L., Veede V. Ravirefraktaarne alkoholvõõrutus: haigusjuhu kirjeldus ja kirjanduse ülevaade Eesti Arst: 101 (10), 578-583, 2022 |
| 4 | Jürgenson A., Sooba E. Põlve- ja puusaliigese endoproteesimise tõenduspõhise taastusravi korraldus Eesti Arst: 101 (Lisa 3), 50-54, 2022 |
| 5 | Kiisla Ü., Sinimäe P. Hormonaalse emakasisese rasestumisvastase süsteemi perforatsioon sigmasoolde. Haigusjuhu kirjeldus Eesti Arst: 101 (12), 700-704, 2022 |
| 6 | Lepik T., Rätsep I. Lemierre’i sündroom Eesti Arst: 101 (5), 315-319, 2022 |
| 7 | Lillo KE. Amatoksiinimürgistus. Kirjanduse ülevaade ja valge kärbseseene mürgistusega kahe patsiendi haigusjuht Eesti Arst: 101 (6-7), 374-381, 2022 |
| 8 | Lõiveke P., Saar A. Kuidas aitab müokardiinfarktiregister leida suurimat tähelepanu vajavaid, suurima suremusriskiga südamelihase infarktiga patsiente? Eesti Arst: 101 (Lisa 1), 37-42, 2022 |
| 9 | Marandi T., Ainla T. Müokardiinfarktiregistri tulevikuvisioon Eesti Arst: 101 (Lisa 1), 50-51, 2022 |
| 10 | Marandi T., Ainla T., Blöndal M., Jürgenson A., Kivistik E., Lukmann A., Lõiveke P., Martinson K., Reinmets J., Saar A., Serg M. Müokardiinfarktihaige käsitlus esimesel aastal pärast haigestumist Eesti Arst: 101 (5), 324-328, 2022 |
| 11 | Nurm M. Taastusravi arendamine Põhja-Eesti Taastusravikeskuses aastatel 1994-2020 Eesti Arst: 101 (Lisa 3), 13-18, 2022 |
| 12 | Orav K. Epilepsia kirurgiline ravi – alakasutatud võimalus ravimrefraktaarse epilepsia raviks Eesti Arst: 101 (8), 430-436, 2022 |
| 13 | Ott M., Haavistu L. Püsiv somatoformne valu Eesti Arst: 101 (1), 37-42, 2022 |
| 14 | Paal P., Krikmann K., Sikk K., Taba P., Elmet K., Suija K. Palliatiivne ravi kui esmatasandi tervishoiuteenus – definitsioon, normid ja tavad Eesti Arst: 101 (6-7), 349-355, 2022 |
| 15 | Piiskoppel P., Palm K. Hüpertroofiline kardiomüopaatia Eesti Arst: 101 (9), 495-500, 2022 |
| 16 | Raud M. Brodie abstsess ja fibroosne kortikaalne defekt Eesti Arst: 101 (10), 584-585, 2022 |
| 17 | Roosipuu A., Vettus E., Vettus R. Nivolumabist tingitud hulgielundipuudulikkus haigusjuhu näitel Eesti Arst: 101 (3), 183-187, 2022 |
| 18 | Ross M., Elme A. Kommentaarid artikli „Trombotsütoos suurendab oluliselt pahaloomulise kasvaja riski” kohta Eesti Arst: 101 (8), 448-449, 2022 |
| 19 | Saar S., Lipping E., Lepp J., Lepner U., Talving P. Läbivate kõhuvigastuste selektiivne mitteoperatiivne käsitlus ning praktika Põhja-Euroopa traumakeskustes Eesti Arst: 101 (4), 225-227, 2022 |
| 20 | Toming A., Kaljurand K. Paratsentraalne akuutne keskmiste kihtide makulopaatia ehk silmapõhja isheemia võrkkesta sügavama kapillaaristiku tasemel – haigusjuhu kirjeldus Eesti Arst: 101 (11), 636-640, 2022 |
| 21 | Tuulik VR., Jürgenson A., Vaht M. Luu-lihaskonna kerge ja mõõduka astme ülekoormussündroomide mõjutamine soojus-, vesi- ja mudaraviga: toimemehhanismis ja efektiivsus Eesti Arst: 101 (Lisa 3), 55-61, 2022 |
| 22 | Umov N., Kampus P. Implanteeritavate südameaparaatide kaug-kodujälgimine Eesti Arst: 101 (9), 487-493, 2022 |
| 23 | Vellend O., Gavrilkina J. Munasarjastruuma. Haigusjuhu kirjeldus koos erialakirjanduse ülevaatega Eesti Arst: 101 (4), 243-246, 2022 |
| Raamatud, dissertatsioonid | |
| 1 | Erikson K. The brain as an end organ in sepsis? Acta Universitatis Ouluensis. D, Medica: 1663, 78, 2022 |
| 2 | Juus E., Laidroo O., Plaas M., Kiivet RA., Jürisson M. Bioloogilised ravimid ninapolüpoosi ravis: tervisetehnoloogia hindamise raport TTH53 Bioloogilised ravimid ninapolüpoosi ravis: tervisetehnoloogia hindamise raport TTH53: 53, 2022 |
| 3 | Lutsar K., Alloja J., Oselin K., Rooväli L., Nurk K., Kiivet RA., Jürisson M. Kaugelearenenud heledarakulise neeruvähi immuunravi kulutõhusus: tervisetehnoloogia hindamise raport TTH55 Kaugelearenenud heledarakulise neeruvähi immuunravi kulutõhusus: tervisetehnoloogia hindamise raport TTH55: 61, 2022 |
| 4 | Põld M., Lepp HL., Uibo O., Juus E., Oad S., Reinson K., Lember M., Saarsalu S., Kiivet RA., Jürisson M. Suukaudse toitmisravi efektiivsus, kulud ja korraldus: tervisetehnoloogia hindamise raport TTH54 Suukaudse toitmisravi efektiivsus, kulud ja korraldus: tervisetehnoloogia hindamise raport TTH54: 72, 2022 |
| Konverentsiteesid | |
| 1 | Adamson-Raieste A. Cancer immunotherapy in early clinical development Eesti Arst: 101 (Lisa 2), 27, 2022 |
| 2 | Bossios A., Bacon AM., Eger K., Paroczai D., Schleich F., Hanon S., Sergejeva S., Zervas E., Katsoulis K., Aggelopoulou A., ... Beliefs about vaccination and relation to COVID-19 vaccination side-effects in asthma patients European Respiratory Journal: 60 (Suppl 66), Tees nr 1085, 2022 |
| 3 | del Castillo FJ., Munoz G., Dominguez-Ruiz M., Ciubotariu C., Piris-Villaespesa M., Ley M., Gainza E., Unceta M., Ceberio L., Fdil N., Ross M., Belanger A., Villarrubia J. NGS-based panel screening of suspected lysosomal disease cases identifies novel pathogenic variants underlying acid sphingomyelinase deficiency (ASMD), Krabbe disease, and lymphatic dysplasia with non-immune hydrops fetalis Molecular Genetics and Metabolism: 135 (2), S36, 2022 |
| 4 | Eger K., Paroczai D., Bacon A., Schleich F., Sergejeva S., ... The effect of the COVID-19 pandemic on severe asthma care in Europe - will care change for good? European Respiratory Journal: 60 (Suppl 66), Tees nr 192, 2022 |
| 5 | Federico M., Stepanishyna Y., Skrypets T., Chiattone C., Prince MH., Pavlovsky A., Lymboussakis A., Manni M., Civallero M., de Souza CA., Hawkes EA., Fiad L., Nair R., Kriachok I., Hitz F., Kostina O., Tomuleasa C., Guarini A., Luminari S. Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of the international prospective T-cell Project 2.0 Hemasphere: 6 (Suppl 3), 123-124, 2022 |
| 6 | Frix A., Heaney LG., Dahlen B., Mihaltan F., Sergejeva S., Doberer D., Popovic-Grle S., Sedlak V., Lehtimäki L., Bourdin A., ... Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study European Respiratory Journal: 60 (Suppl 66), Tees nr 2387, 2022 |
| 7 | Heinsar S., Bartnikowski N., Hartel G., Seah EP., Colombo SM., Farah SM., Rätsep I., Pauls J., Fraser JF., Suen J. In vitro evaluation of hemodynamic energy production and circuit loss using four different ECMO arterial cannulae Artificial Organs: 46 (1), E12-E13, 2022 |
| 8 | Iskül S., Zemtsovskaja G. Pitfalls of introducing the methotrexate method in a highly automated laboratory Clinica Chimica Acta: 530 (Suppl 1), S440, 2022 |
| 9 | Iskül S., Võsa L., Zemtsovskaja G. Validating the Roche Cobas serum haemolysis index for the assessment of plasma cell-free haemoglobin concentration Eesti Arst: 101 (Supplement 4), 39, 2022 |
| 10 | Keba M., Asser A. Ülevaade elektrilise tõukerattaga sõitmise tagajärjel esinevatest ajutraumadest: haigusjuhtude analüüs Põhja-Eesti Regionaalhaiglas aastatel 2019–2021 Eesti Arst: 101 (Lisa 5), 47, 2022 |
| 11 | Keernik M., Tammur P., Šamarina U., Kaare A., Palk K., Ilisson P., Tooming M. Landscape of genetic alterations of Estonian patients with MDS and AML diagnosis Eesti Arst: 101 (Supplement 4), 30, 2022 |
| 12 | Kurg K., Planken A., Kurg R. Melanoomipatsientide vereseerumist puhastatud ekstratsellulaarsete vesiikulite proteoomiline ja biokeemiline analüüs Eesti Arst: 101 (Lisa 5), 19, 2022 |
| 13 | Kurg K., Planken A., Kurg R. Proteomic and biochemical analysis of extracellular vesicles isolated from the blood serum of patients with melanoma Eesti Arst: 101 (Supplement 4), 40, 2022 |
| 14 | Kõljalg S., Vaikjärv R., Smidt I., Rööp T., Chakrabarti A., Kasenõmm P., Mändar R. Erütritooli ja ksülitooli efekt peritonsillaarset abstsessi põhjustanud Streptococcus pyogenes’e tüvedele Eesti Arst: 101 (Lisa 5), 31, 2022 |
| 15 | Kõre AC., Serg M., Voitk J., Roose I., Eha J., Pauklin P., Kampus P. Resünkroniseeriva ja kardioverter-defibrillaatorravi kandidaatide tsentraalne hemodünaamiline profii Eesti Arst: 101 (Lisa 5), 11, 2022 |
| 16 | Kütt M. Harmonisation in satellite labs Eesti Arst: 101 (Supplement 4), 30, 2022 |
| 17 | Kütt M. What do people ask from laboratory doctors? Eesti Arst: 101 (Supplement 4), 25, 2022 |
| 18 | Laisaar T., Vanakesa T., Sarana B., Almre I., Saar A. Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic Journal of Thoracic Oncology: 17 (9 Suppl), S309-S310, 2022 |
| 19 | Luksta M., Ümarik T., Bausys A., Reinsoo A., Rackauskas R., Anglickiene G., Kryzauskas M., Tõnismäe K., Senina V., Seinin D., Bausys R., Strupas K. The optimal timing for gastrectomy after neoadjuvant chemotherapy European Journal of Surgical Oncology: 48 (2), e178, 2022 |
| 20 | Mihnovitš V., Põld K., Paasma R. Cortinarius rubellus poisoning in Estonia: a case series Clinical Toxicology: 60 (Suppl 1), 32, 2022 |
| 21 | O'Brien MER., Paz-Ares L., Jha N., Dafni U., Oselin K., Havel L., Esteban E., Isla D., Martinez-Marti A., Faehling M., ... EORTC-1416-LCG/ETOP 8-15 - PEARLS/KEYNOTE-091 study of pembrolizumab versus placebo for completely resected early-stage non-small cell lung cancer (NSCLC): Outcomes in subgroups related to surgery, disease burden, and adjuvant chemotherapy use Journal of Clinical Oncology: 40 (16 Suppl), Tees nr 8512, 2022 |
| 22 | Paats J., Adoberg A., Arund J., Fridolin I., Holmar J., Leis L., Pilt K., Tanner R., Uhlin F., Luman M. Medicines intake influences accuracy of the uremic retention molecules' optical monitoring in spent dialysate: the case of uremic toxin uric acid and paracetamol Kidney International Reports: 7 (2 Suppl), S277-S278, 2022 |
| 23 | Peebo K., Saluveer E., Küünarpuu H., Orgse T., Harro J. First-Episode Psychosis Integrative Treatment: Estonian Experience Eesti Arst: 101 (Lisa 2), 54, 2022 |
| 24 | Peters S., Besse B., Marreaud S., Dafni U., Oselin K., Havel L., Esteban Gonzalez E., Isla D., Martinez-Marti A., Faehling M., Tsuboi M., Lee JS., Nakagawa K., Yang J., Keller SM., Mauer ME., Jha N., Stahel RA., Paz-Ares L., O’Brien MER. PD-L1 expression and outcomes of pembrolizumab and placebo in completely resected stage IB-IIIA NSCLC: Subgroup analysis of PEARLS/KEYNOTE-091 Annals of Oncology: 33 (Suppl 7), Tees nr 930MO, 2022 |
| 25 | Pikta M., Saks K., Ross M., Banys V. Testing strategy for laboratory monitoring of Hemophilia A patients treated with Emicizumab Clinica Chimica Acta: 530 (Suppl 1), S186, 2022 |
| 26 | Pikta M., Szanto T., Banys V. Evaluation of within-subject variation of VWF multimers assay Research and Practice in Thrombosis and Haemostasis: 6 (Suppl 1), 616, 2022 |
| 27 | Põder H., Kaasik B., Sokk-Kaha A. Clinical case of infantile hemangioma – is it as easy to treat as to diagnose? 5th Baltic Paediatric Congress & 23rd Estonian Paediatric Association Congress. Programme and abstract book: 103, 2022 |
| 28 | Roht L., Hyldebrandt HK., Stormorken AT., Nordgarden H., Sijmons RH., Bos DK., Riegert-Johnson D., Mantia-Macklin S., Muru K., Kahre T., Õunap K. Phenotype of six families with AXIN2-oligodontia-colorectal cancer syndrome. Cleft palate as a new feature of this syndrome? European Journal of Human Genetics: 30 (Suppl 1), 372, 2022 |
| 29 | Roht L., Põder H., Paluste M., Veri K. Myotonic dystrophy type 1 - different clinical manifestations in one family 16th BCNA Conference: 53, 2022 |
| 30 | Saar M., Vaikjärv R., Parm Ü., Jaagura M., Kasenõmm P., Štšepetova J., Mändar R. Tonsillide ja abstsessi mäda mikrobioomi molekulaarne analüüs peritonsillaarse abstsessi korral Eesti Arst: 101 (Lisa 5), 13, 2022 |
| 31 | Schwarz G., Bonato S., Lanfranconi S., Matusevicius M., Ghione I., Valcamonica G., Tsivgoulis G., Paiva Nunes A., Mancuso M., Zini A., Candelaresi P., Rand VM., Comi GP., Mazya MV., Ahmed N. Safety and efficacy of endovascular thrombectomy plus intravenous thrombolysis vs. intravenous thrombolysis alone in mild symptoms strokes with large vessel occlusion: propensity score matched analysis European Stroke Journal: 7 (1 Suppl), 114, 2022 |
| 32 | Sepp T., Kukk L., Korotõtš D. Radiation-induced rectourethral fistulas, single centre experience in management European Urology Open Science: 40 (Suppl 1), S46, 2022 |
| 33 | Serban M., Gallois M., Urtubey T., Nout R., de Leeuw A., Fokdal L., Assenholt M., Spampinato S., Bruheim K., Segedin B., ..., Valgma M. Effect of dose and fractionation de-escalation in low-risk cervix cancer treated with EBRT and BT Radiotherapy and Oncology: 170 (Suppl 1), S451-S453, 2022 |
| 34 | Serg M. New drugs for treating dyslipidemia Eesti Arst: 101 (Lisa 2), 37, 2022 |
| 35 | Säflund M., Matusevicius M., Egido JA., Ferro JM., Kõrv J., Melis M., Peeters A., Petruzzellis M., Rand VM., Vilionskis A., Mazya MV., Moreira T., Ahmed N. Initiation of direct oral anticoagulation after reperfusion therapy in ischemic stroke in clinical practice: results from SITS-International Stroke Registry European Stroke Journal: 7 (1 Suppl), 201, 2022 |
| 36 | Zordania R., Kuuse K., Murumets Ü., Tarelkin E., Roht L. Genetic counselling of patients with mental retardation/disability and autism spectrum disorders 5th Baltic Paediatric Congress & 23rd Estonian Paediatric Association Congress. Programme and abstract book: 73-74, 2022 |
| 37 | Tamm M., Annilo T., Oselin K., Kals M., Keerma K., Kivistik PA., Nurm M., Saare M., Jaal J., Tõnisson N. Liquid biopsy in lung cancer patients shows advantages compared to FFPE tissue mutational analysis European Journal of Human Genetics: 30 (Suppl 1), 405-406, 2022 |
| 38 | Tomberg K., Pikta M. Hemogram reference values in Estonia Eesti Arst: 101 (Supplement 4), 13, 2022 |
| 39 | Vaagen K., Zemtsovskaja G. Harmonization of electrophoretic investigations in the evaluation of monoclonal gammopathies in Estonia Eesti Arst: 101 (Supplement 4), 29, 2022 |
| 40 | Valter A. Current state of art - cancer immunotherapy in clinical practice Eesti Arst: 101 (Lisa 2), 26, 2022 |
| 41 | Valter A., Luhari L., Pisarev H., Truumees B., Planken A., Smolander OP., Oselin K. Genetic alterations as independent prognostic factors to predict the type of recurrence of lung cancer Annals of Oncology: 33 (Suppl 7), Tees nr 1684P, 2022 |
| 42 | Viigimaa M. Erectile dysfunction in cardiovascular disorders Journal of Rehabilitation Medicine: 54 (Suppl), 9, 2022 |
| 43 | Villarrubia J., Munoz G., Ciubotariu C., Dominguez-Ruiz M., Piris-Villaespesa M., Unceta M., Ceberio L., Church H., Norouzi M., Ross M., Perez-de Pedro I., Stepien KM., del Castillo FJ. Adult acid sphingomyelinase deficiency (Niemann-Pick disease type B): A difficult pathway to a diagnosis in 4 novel cases Molecular Genetics and Metabolism: 135 (2), S125, 2022 |
| Muud publikatsioonid | |
| 1 | Adoberg A. Kui neerud on natuke laisad ehk kuidas seletada patsiendile neeruanalüüside tulemusi Perearst: 9 (183), 49-51, 2022 |
| 2 | Ambos A. Ameerika Diabeedi Assotsiatsiooni 2022. aasta diabeedi käsitluse standardid Lege Artis: 1 (6), 53-57, 2022 |
| 3 | Anton L. Pulmonaalhüpertensiooni käsitlus 2022. aasta Euroopa Kardioloogide Seltsi ravijuhendis Lege Artis: 7 ( 6), 12-15, 2022 |
| 4 | Eisen M. Raske atoopilise dermatiidi ravivõimalused EuroGuiDermi juhendi põhjal kohandatuna Eesti oludele Lege Artis: 8 (6), 27-28, 2022 |
| 5 | Elme A. Erakorraliste onkoloogiliste olukordade äratundmine esmatasandil Perearst: 8 (182), 26-29, 2022 |
| 6 | Helmdorf M. Statiinravi alustamine eakatel Perearst: 7 (181), 22-24, 2022 |
| 7 | Kaarde P. Hormoonasendusravi võimalikud kasud ja riskid Lege Artis: 2 (6), 16-18, 2022 |
| 8 | Kaha T. Patoloogiliste armide korral võib leida abi konservatiivsest ravi Perearst: 2 (176), 45-48, 2022 |
| 9 | Kaha T. Põletuste ravist pereõdedele Pereõde: 3 (39), 41-42, 2022 |
| 10 | Kala K. Kuiva silma sündroom Perearst: 10 (184), 45-47, 2022 |
| 11 | Kaur I. Kaalukirurgia ja metaboolne kirurgia Lege Artis: 4 (6), 12-16, 2022 |
| 12 | Kippasto N. Kasvaja metastaasid Perearst: 10 (184), 16-18, 2022 |
| 13 | Kõdar H., Palk K., Ross M. Ägedad leukeemiad ja nende eduka ravi kaugmõjud Perearst: 2 (176), 15-18, 2022 |
| 14 | Kütner R. Rinnatervis on oluline kogu perele Lege Artis: 5 (6), 3, 2022 |
| 15 | Kütner R., Roht L. Geneetiliste faktorite roll rinnavähi tekkes Perearst: 1 (175), 42-44, 2022 |
| 16 | Kütt M. Tsirkuleerivad ja koelised kasvajamarkerid ning nende kasutamine kliinilises praktikas Lege Artis: 1 (6), 20-25, 2022 |
| 17 | Lauri V. Autismispektri häire – mida see endast kujutab, kuidas üles leida eripära ja kuidas sekkuda? Perearst: 3 (177), 13-16, 2022 |
| 18 | Lotman EM. Cor pulmonale Perearst: 4 (178), 56-59, 2022 |
| 19 | Lotman EM. Haigusjuht: tahhükardia-bradükardia sündroom Lege Artis: 1 (6), 81-83, 2022 |
| 20 | Lotman EM. Suukaudsete antitrombootiliste ravimite kasutamine kodade virvendusarütmia ja aterosklerootilise kardiovaskulaarhaiguse ravis Perearst: 6 (180), 55-58, 2022 |
| 21 | Luman M. Neerukahjustusega diabeetiku ravivõimalused ja -eelistused Perearst: 3 (177), 47-53, 2022 |
| 22 | Lõokene M. Depressioon meestel – mida märgata ja kuidas aidata? Perearst: 4 (178), 63-66, 2022 |
| 23 | Lõokene M. Ülevaade transkraniaalsest alalisvoolustimulatsioonist Perearst: 7 (181), 57-60, 2022 |
| 24 | Mukk P. GOLD 2022 uuendused pööravad tähelepanu ka COVID-19 pandeemiale Perearst: 5 (179), 59-64, 2022 |
| 25 | Niine-Roolaht EM. Euroopa endomeetriumivähi ravijuhendi lühitutvustus Teataja / Eesti Naistearstide Selts: 69, 26-28, 2022 |
| 26 | Putnik K. Melanoomi esinemissagedus kasvab kogu maailmas Lege Artis: 4 (6), 43-47, 2022 |
| 27 | Rahu M. Viskosuplementatsioon osteoartriidi korral Lege Artis: 6 (6), 14-17, 2022 |
| 28 | Roht L. Rinnavähist geneetiku vaatevinklist Lege Artis: 5 (6), 8-11, 2022 |
| 29 | Rugo M. Sagedasemad vulvovaginiidid Perearst: 8 (182), 59-60, 2022 |
| 30 | Rugo M. Viljatuse põhjuste kirurgilised ravivõimalused naistel Lege Artis: 2 (6), 10-12, 2022 |
| 31 | Salus M. Polüneuropaatia – diagnoosimise põhitõed ja esmane käsitlus Perearst: 11 (185), 74-77, 2022 |
| 32 | Salus M. Vitamiin B12 inimese närvisüsteemis Lege Artis: 4 (6), 68-70, 2022 |
| 33 | Serg M., Tsvetkov E., Sepp A., Viigimaa M. Düslipideemia müokardiinfarktiga patsientidel – multidistsiplinaarne analüüs Lege Artis: 5 (6), 45-47, 2022 |
| 34 | Sergejeva S. Kroonilised obstruktiivsed kopsuhaigused: kokkuvõte hiljutisest kopsuarstide seminarist Perearst: 8 (182), 31-33, 2022 |
| 35 | Sergejeva S., Melnikova R., Sadam T. Täiskasvanuea allergilisest astmast perearstile Perearst: 5 (179), 51-56, 2022 |
| 36 | Suuroja T. Igal aastal avastatakse Eestis umbes 100 uut neuroendokriinkasvaja juhtu Perearst: 10 (184), 67-68, 2022 |
| 37 | Varik M., Kõdar H Tsütopeeniad ja nende käsitlus Perearst: 9 (183), 55-60, 2022 |
| 38 | Varik M., Kõdar H. Tsütopeeniad ja nende käsitlus Perearst: 10 (184), 19-23, 2022 |
| 39 | Viigimaa I. Kroonilise lümfotsüütleukeemia ravi – saabunud on uus ajastu Lege Artis: 7 ( 6), 47-48, 2022 |
| 40 | Viigimaa M. Oleme unustanud, et rohkem kui pool südame-veresoonkonnahaigustest on ennetatavad Perearst: 4 (178), 31, 2022 |
| 41 | Viigimaa M. Oleme unustanud, et rohkem kui pool südame-veresoonkonnahaigustest on ennetatavad Pereõde: 2 (38), 33, 2022 |
| 42 | Viigimaa M., Tänavsuu T. Terve südame raamat Terve südame raamat: 108, 2022 |
| 43 | Viks L. GOLD-i 2022. aasta ravijuhend: kroonilise obstruktiivse kopsuhaiguse ravisoovitused Perearst: 1 (175), 59-65, 2022 |
| 44 | Viks L. Kroonilise obstruktiivse kopsuhaiguse olemusest ja hapnikravist Lege Artis: 2 (6), 41-46, 2022 |
| 45 | Viks L. Kroonilise obstruktiivse kopsuhaiguse olemusest ja hapnikravist Perearst: 6 (180), 37-41, 2022 |